Notably, among young patients diagnosed with breast cancer below the age of 30, approximately 25% of them carried BRCA2 deleterious mutations and 6.2% of them harbored ATM mutations, significantly higher than in women diagnosed ≥ 40 years (P=0.002), (Table 2 and Figure 4B). The gene discussed is BRCA2; the disease is breast cancer.